Multidimensional characterization of motor impairment in distal and myofibrillar myopathies: a multicenter study integrating functional and digital outcome measures
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Distal and myofibrillar myopathies (DM and MFM) are overlapping groups of muscle diseases. Functional scales often fail to capture distal muscle weakness, hindering patient stratification and trial endpoint selection. This study aims to characterize motor impairment in DM and MFM using functional, digital, and patient-reported outcome measures (PROMs) and to identify functional phenotypes through data-driven clustering. METHODS: In this multicenter study, 51 adults with genetically confirmed DM or MFM (13 genes) underwent a standardized assessment including: Motor Function Measure (MFM32), timed tests, digital dynamometry (MyoTools for distal muscles), and instrumented gait analysis (Loadsol® insoles). PROMs included IBM-FRS and QoL-gNMD. Hierarchical clustering was applied. RESULTS: MFM32 scores were sensitive to the heterogeneity of motor function within the cohort, discriminating among ambulation categories (p<0.001), whereas the distal domain showed a ceiling effect. MyoTools detected distal weakness in over 80% of patients, including those with preserved functional scores. Instrumented gait analysis identified specific alterations in heel strike and foot off phases; heel strike duration correlated with ankle dorsiflexion strength (R=0.67). Cluster analysis identified four functional phenotypes, independent of genetic diagnosis: (1) moderate-to-severe global impairment; (2) anterior compartment predominance; (3) selective lower leg posterior compartment involvement; (4) relatively preserved performance. The IBM-FRS reflected objective motor impairment, while QoL-gNMD highlighted discrepancies between impairment and perceived disease impact. CONCLUSIONS: A multidimensional approach integrating digital measures significantly enhances the characterization of DM and MFM, providing granular data overlooked by traditional scales. Phenotype-based stratification may optimize trial endpoint selection and improve outcome measures sensitivity.
Source: Journal of Neurology
Authors: Sara Bortolani, Mauro Monforte, Valerio Trombetta, Eleonora Torchia, Beatrice Ravera, Alex Vicino, Giulia Tammam, Luisa Villa, Marco Rabuffetti, Alberto Marzegan, Riccardo Piovesan, Enrica Rolle, Tiziana Enrica Mongini, Enzo Ricci, Sabrina Sacconi, Lorenzo Maggi, Jean-Yves Hogrel, Giorgio Tasca
Institutions: Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Università Cattolica del Sacro Cuore, Centre Hospitalier Universitaire Vaudois, Fondazione IRCCS Istituto Neurologico Carlo Besta, University of Lausanne, Centre Hospitalier Universitaire de Nice, Don Carlo Gnocchi Foundation, University of Turin, Institut de Myologie, Newcastle upon Tyne Hospitals NHS Foundation Trust, NIHR Newcastle Biomedical Research Centre, Newcastle University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
Funders: Ministero della Salute, AFM-Téléthon
Awards: G5830467628, G6168855936, G9001359412
OpenAlex ID: W7236287167
